Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,077
Closed -$938K 295
2023
Q1
$938K Buy
8,077
+4,216
+109% +$472K 0.24% 126
2022
Q4
$437K Sell
3,861
-402
-9% -$44.1K 0.12% 163
2022
Q3
$343K Buy
+4,263
New +$361K 0.16% 160

Other funds holding DXCM

Exos TFP Holdings's DXCM Position: Q2 2023 in Review

Exos TFP Holdings sold out of DexCom (DXCM) in Q2 2023, closing a stake of 8,077 shares — an estimated $938K sold.

Exos TFP Holdings first reported a position in DXCM in Q3 2022 and held it in 3 quarters. The position peaked at $938K in Q1 2023. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Exos TFP Holdings reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 8,077 DexCom shares in Q2 2023, an estimated $938K.
  • Exos TFP Holdings first reported a position in DexCom in Q3 2022 and held it in 3 quarters.
  • Exos TFP Holdings's DexCom position peaked at $938K in Q1 2023.
  • 954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.